Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: The ULTRADISCO study

European Journal of Heart Failure

Volumn 13, Issue 3, 2011, Pages 337-346

  Giglioli, Cristina ^a   Landi, Daniele ^a   Cecchi, Emanuele ^a   Chiostri, Marco ^b   Gensini, Gian Franco ^b   Valente, Serafina ^a   Ciaccheri, Mauro ^a   Castelli, Gabriele ^a   Romano, Salvatore Mario ^b  

^a Department of Heart and Vessels ^*  (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Diuretic therapy; Haemodynamic; Heart failure; Minimally invasive monitoring; Ultrafiltration

Indexed keywords

ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; FUROSEMIDE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; FEMALE; HEART CYCLE; HEART FAILURE; HEART INDEX; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULTRAFILTRATION; VASCULAR RESISTANCE;

ANALYSIS OF VARIANCE; CREATININE; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; FUROSEMIDE; HEART FAILURE; HEMODYNAMICS; HEMOFILTRATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79951829308     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq207     Document Type: Article

References (38)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-151G.
2. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, preliminary observations from the first 100.000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149:209-216. (Pubitemid 40348525)
3. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
4. Bart BA, Boyle A, Bank J, Anand I, Olivari MT, Kraemer M, Mackendaz S, Sobotka PA, Schollmeyer M, Goldsmith SR. Ultrafiltration vs. usual care for hospitalized patients with heart failure: the relief for acutely fluid-overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial. J Am Coll Cardiol 2005;46:2043-2046. (Pubitemid 41713589)
5. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P. Early ultrafiltration in patients with decompensated heart failure and diuretic resistence. J Am Coll Cardiol 2005; 46:2047-2051. (Pubitemid 41713590)
6. ADHERE-Acute Decompensated Heart Failure National Registry: Q1 2004 National Benchmark Report. Atlanta, GA: Adair-Greene Healthcare Communications; 2004 p1-21.
7. Weber KT. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain. J Am Coll Cardiol 2004;44:1308-1310. (Pubitemid 39208890)
8. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003;42:705-708. (Pubitemid 37000189)
9. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985; 103:1-6. (Pubitemid 15068490)
10. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollimeyer MP, Sobotka PA. Ultra-filtration vs. intravenous diuretics for patients hospitalized for acute decompen-sated heart failure. J Am Coll Cardiol 2007;49:675-683. (Pubitemid 46205043)
11. Agostoni P, Marenzi G, Lauri G, Perego G, Schianni M, Sganzerla P, Guazzi MD. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994;96:191-199.
12. Giglioli C, Landi D, Gensini GF, Valente S, Cecchi E, Scolletta S, Chiostri M, Romano SM. Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: a preliminary report. Blood Purif 2010;1:44-51.
13. Romano SM, Pistolesi M. Assessment of cardiac output from systemic arterial pressure in humans. Crit Care Med 2002;30:1834-1841. (Pubitemid 34879600)
14. Romagnoli S, Romano SM. Estimation of hemodynamic parameters by arterial waveform: available technologies. Anesth Anal 2010;110:257-258.
15. Romano SM, Olivotto I, Chiostri M, Giglioli C, Margheri M, Gensini GF. Minimally invasive and non invasive hemodynamic monitoring of the cardiovascular system: available options and future perspectives. Curr Cardiol Rev 2006;4:37-39. (Pubitemid 44082920)
16. Modesti PA, Gamberi T, Bazzini C, Borro M, Romano SM, Cambi GE, Corvi A, Dorigo W, Paparella L, Pratesi C, Carini M, Gensini G, Modesti A. Response of serum proteome in patients undergoing infrarenal aortic aneurysm repair. Anesthesiology 2009;111:844-854.
17. Gardner RM. Direct blood pressure measurement-dynamic response requirements. Anesthesiology 1981;54:227-236. (Pubitemid 11154044)
18. Promonet C, Anglade D, Menaouar A, Bayat S, Durand M, Ebherard D, Grimbert F. Time-dependent pressure distortion in a catheter-transducer system. Anesthesiology 2000;92:208-218. (Pubitemid 30027466)
19. Felker MG. Diuretic management in heart failure. Congest Heart Fail 2010; 16(Suppl. 1):S68-S72.
20. Sica D, Oren RM, Gottwald MD, Mills RM; Scios 351 Investigators. Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction. Clin Cardiol 2010;33: 330-336.
21. Marenzi G, Grazi S, Giraldi F, Lauri G, Perego G, Guazzi M, Salvioni A, Guazzi MD. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 1993; 94:49-56. (Pubitemid 23021171)
22. Marenzi G, Lauri G, Grazi M, Assanelli E, Capodonico J, Agostoni P. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001;38:963-968. (Pubitemid 32912695)
23. Sharma A, Hermann DD, Mehta RL. Clinical benefit and approach of ultrafiltra-tion in acute heart failure. Cardiology 2001;96:144-154. (Pubitemid 34114124)
24. Libetta C, Sepe V, Zucchi M, Campana C, Dal Canton A. Standard haemodiafiltra-tion improves diuretic responsiveness in advanced congestive heart failure. Cardiology 2006;105:122-123. (Pubitemid 43189787)
25. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation 1987;75:IV80-IV92.
26. Agostoni PG, Marenzi GC. Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 2001;96:183-189.
27. Hill JA, Yancy CW, Abraham WT. Beyond diuretics: management of volume overload in acute heart failure syndromes. Am J Med 2006;119:S37-S44. (Pubitemid 44738818)
28. Boyle A, Sobotka PA. Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail 2006;12:247-249.
29. Ronco C, Ricci Z, Bellomo R, Bedogni F. Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology 2001;96: 155-168. (Pubitemid 34114125)
30. Costanzo MR. Ultrafiltration in the management of heart failure. Curr Opin Crit Care 2008;14:524-530.
31. Mendoza DD, Cooper HA, Panza JA. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 2007;153:366-370. (Pubitemid 46328753)
32. Cotter G. Role of cardiac power in heart failure. Curr Opin Cardiol 2003;18:215-222. (Pubitemid 36960470)
33. Carabello BA. Evolution of the study of left ventricular function: everything old is new again. Circulation 2002;105:2701-2703. (Pubitemid 34615137)
34. Jaski BE, Ha J, Denys BG, Lamba S, Trupp RJ, Abraham WT. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003;9:227-231. (Pubitemid 36734320)
35. Hoffmann JN, Faist E. Removal of mediators by continuous haemofiltration in septic patients. World J Surg 2001;25:651-659. (Pubitemid 32441442)
36. Tallman RD, Dumond M, Brown D. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary by-pass. Perfusion 2002;17: 111-115. (Pubitemid 34266076)
37. Rubboli A, Sobotka PA, Euler DE. Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am J Physiol 1994; 267:H1054-H1061. (Pubitemid 24299055)
38. Ludwig LL, Schertel ER, Pratt JW, McClure DE, Ying AJ, Heck CF, Myerowitz PD. Impairment of left ventricular function by acute cardiac lymphatic obstruction. Cardiovasc Res 1997;33:164-171. (Pubitemid 27019111)